about
Pharmacology and rationale for imatinib in the treatment of sclerodermaApelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertensionOptimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment courseIntegrated care and optimal management of pulmonary arterial hypertensionRole for miR-204 in human pulmonary arterial hypertensionmTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia.down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension.Fibrosis of pulmonary vascular remodeling in carotid artery-jugular vein shunt pulmonary artery hypertension model of ratsRapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in micePDGF enhances store-operated Ca2+ entry by upregulating STIM1/Orai1 via activation of Akt/mTOR in human pulmonary arterial smooth muscle cells.Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobinDifferential effects of formoterol on thrombin- and PDGF-induced proliferation of human pulmonary arterial vascular smooth muscle cells.Sildenafil for pulmonary arterial hypertension: when blue turns into white.Therapeutic effect of low-dose imatinib on pulmonary arterial hypertension in dogs.Regulation of ca(2+) signaling in pulmonary hypertension.Emerging treatments for pulmonary arterial hypertension.The potential for resident lung mesenchymal stem cells to promote functional tissue regeneration: understanding microenvironmental cues.Role of cellular bioenergetics in smooth muscle cell proliferation induced by platelet-derived growth factor.Platelets in lung biology.MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1Prednisolone inhibits PDGF-induced nuclear translocation of NF-kappaB in human pulmonary artery smooth muscle cells.The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice.Versican accumulates in vascular lesions in pulmonary arterial hypertension.Therapeutic advances in pulmonary arterial hypertension.Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension.Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.MiR-328 targeting PIM-1 inhibits proliferation and migration of pulmonary arterial smooth muscle cells in PDGFBB signaling pathway.Advances in therapies for pediatric pulmonary arterial hypertension.Treatment of pulmonary arterial hypertension with targeted therapies.Targeted approaches to the treatment of pulmonary hypertension.Targeting PDGF pathway in pulmonary arterial hypertension.Current and advancing treatments for pulmonary arterial hypertension in childhood.Targeting the platelet-derived growth factor signalling in cardiovascular disease.Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: The Difficulty in Interpreting Proof-of-Concept Studies.Advances in treatment of pulmonary arterial hypertension: patent review.Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.Safety and feasibility of obtaining wedged pulmonary artery samples and differential distribution of biomarkers in pulmonary hypertension.Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension.Sustained Activation of Rho GTPases Promotes a Synthetic Pulmonary Artery Smooth Muscle Cell Phenotype in Neprilysin Null Mice.
P2860
Q26825153-0CDDA5E1-E0C9-4D6D-9069-30841261E504Q27010531-E94908C8-3514-4D7A-8033-6B71AFFAF2A1Q27023074-090B0F01-585C-41E2-B951-E84C030FA362Q34417785-BF7132AB-A863-4BD1-A993-3EEA32998B98Q34681312-82D00811-60DE-4F3B-928E-0CDF830FCCE6Q35003274-90BDBD23-53D1-492A-A4B7-057EDADE9D6BQ35150101-69931FFF-A5B0-47E2-B484-4402DDF05231Q35533520-B3B0B6D7-53CE-4AB8-8C1A-4379D7BE7421Q35619912-DF1C1055-0C86-4336-ADA1-C520E586AFB3Q35677930-B51C0DD5-EA8C-4A9E-8F6C-67976C85F256Q35895524-6501039D-01A5-4C8D-A202-0DBA762A9F93Q35990633-1DB0FBFE-ED45-4EFF-A000-0BD892095BD6Q36535586-BF24E060-F206-4179-9A84-347C7A4EA89CQ36573907-70A101BA-51B7-46E7-91D7-E4AAE531E452Q36613243-26E4F78A-D694-4FB5-BD6A-9B66A46DACAAQ36628777-897C5CE5-F9F9-49B2-95F1-27D8E27AA000Q36634252-AB70B247-0BFE-4B2D-8F59-86A636CCDD95Q36790737-2F611A9E-210D-4763-BFDF-30B062CC013BQ36808761-706C203A-9541-4E51-B330-67EE94DD4FEAQ36897267-14F5186E-1DAB-4E52-95C9-15F0209A44E9Q36943405-59B74459-66A1-478F-8364-DDCC96DD2E12Q36956163-2EF2C993-56E3-49D5-8777-E031A55F923DQ37180290-78E1DF4A-D885-4928-ACBF-C37B61DFDDA9Q37248333-8ADC285F-1D5A-41F8-8CC2-09C94B0C2D18Q37362631-6A7172DB-FE80-45AE-96DD-F8F6E0CDFE28Q37406416-BFBE0B36-CB2F-4EAF-BA0A-A446531D80DBQ37656327-AC569319-EC5E-43A2-B7AD-8385C50626C7Q37688178-AE699BA9-B549-446B-8B19-60BF96C50BFCQ37755020-80C5C3BB-FF8A-464E-A9C6-60183ECAE8F9Q37902509-27DE6CC0-959C-422E-B1B5-F7665ECEA681Q37995985-0C93470F-C497-440F-8753-CBAAB4C35C45Q38038222-070C5C17-296F-4C9F-BF25-0BA71C3ADE51Q38232339-D6CFC50F-101A-4205-B660-B6A012562909Q38567570-5D33E8A4-652B-45C9-B4D4-D2AC45E1E3D7Q38733768-D807066D-4205-4F11-A84D-A697D8DB4120Q39206788-1090612E-CD5E-49CF-B220-B864CEC714F0Q39879690-3D41FD25-C820-4D1E-AA35-9B0ACFE0624BQ41763006-74F84873-BDD0-4C8E-93D8-D4F677CC2AA7Q42737164-08DCA155-EA4B-4695-8472-ADD0FF52114FQ47345004-10AF0A6B-BCDF-40E3-AE45-020C5649C65B
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
PDGF signaling in pulmonary arterial hypertension.
@ast
PDGF signaling in pulmonary arterial hypertension.
@en
PDGF signaling in pulmonary arterial hypertension.
@nl
type
label
PDGF signaling in pulmonary arterial hypertension.
@ast
PDGF signaling in pulmonary arterial hypertension.
@en
PDGF signaling in pulmonary arterial hypertension.
@nl
prefLabel
PDGF signaling in pulmonary arterial hypertension.
@ast
PDGF signaling in pulmonary arterial hypertension.
@en
PDGF signaling in pulmonary arterial hypertension.
@nl
P2860
P356
P1476
PDGF signaling in pulmonary arterial hypertension.
@en
P2093
Robyn J Barst
P2860
P304
P356
10.1172/JCI26593
P407
P577
2005-10-01T00:00:00Z